![Tamar Rubinstein](https://assets.montefioreeinstein.org/profiles/images/13686-tamar-rubinstein.jpg)
Tamar Rubinstein, M.D., M.S.
- Assistant Professor, Department of Pediatrics (Pediatric Rheumatology)
- Assistant Professor, Department of Psychiatry and Behavioral Sciences
Area of research
- Pediatric Rheumatology; Systemic Lupus Erythematosus; Psychosocial and Mental Health in Youth with Rheumatologic Conditions
Phone
Location
- Montefiore Medical Center 3415 Bainbridge Avenue Bronx, NY 10467
Research Profiles
Professional Interests
Tamar Rubinstein, MD, MS, is a Pediatric Rheumatologist at Children's Hospital at Montefiore and an Assistant Professor of Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is the treatment of children, adolescents and young adults with complex rheumatologic diseases, with a special interest in leading multidisciplinary care of patients with Systemic Lupus Erythematosus (SLE).
Dr. Rubinstein obtained her Medical Doctorate and Master of Science in Clinical Research Methods at Albert Einstein College of Medicine. After completing her residency at Johns Hopkins Hospital, Dr. Rubinstein went on to complete her fellowship training in Pediatric Rheumatology at Children's Hospital at Montefiore in 2016.
Dr. Rubinstein has authored numerous publications and continues to actively propose new lines of research with hopes to improve the mental health and SLE disease outcomes in youth. She is an active member of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) and a leader of the CARRA Mental Health Workgroup. Dr. Rubinstein is a recipient of the Lupus Foundation of America Career Development Award, the Rheumatology Research Foundation K-Bridge Award, and has received additional funding from CARRA and the Arthritis Foundation for her research. She is currently a lead investigator in the Einstein Pediatric Lupus Cohort.
Selected Publications
Freilich B, Feirsen N, Welton E, Mowrey W, Rubinstein T. Validation of the Attention, Memory, and Frontal Abilities Screening Test (AMFAST). Assessment. 2019 Jan 9, doi: 10.1177/ 1073181118822734.
Smith EMD, Eleuteri A, Goilav B, Lewandowski L, Phuti A, Rubinstein T, Wahezi D, Jones CA, Marks SD, Corkhill R, Pilkington C, Tullus K, Putterman C, Scott C, Fisher AC, Beresford MW. A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity. Clinical Immunology. 2019 Jan; 198:71-78.
Knight A, Vickery M, Faust L, Muscal E, Davis A, Harris J, Hersh A, Rodriguez M, Onel K, Rubinstein T, Washington N, Weitzman ER, Conlon H, Woo JMP, Gerstbacher D, von Scheven E; CARRA Investigators. Gaps in mental health care for youth with rheumatologic conditions: a mixed methods study of perspectives from behavioral health providers [published online June 28, 2018]. Arthritis Care Res (Hoboken). doi: 10.1002/acr.23683
Rubinstein T, Mowrey W, Ilowite N, Wahezi D; CARRA Investigators. Delays to care in pediatric lupus patients from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis Care and Research. 2018; 70(3):420-427.
Rubinstein T, Davis A, Rodriguez M, Knight A. Addressing Mental Health in Pediatric Rheumatology. Current Treatment Options in Rheumatology. 2018; 4(1):55-72.
Davis A, Rubinstein T, Rodriguez M, Knight A. Mental Health Care for Youth with Rheumatologic Diseases - Bridging the Gap. Pediatric Rheumatology. 2017 Dec;15(1):85.
Knight AM, Vickery ME, Muscal E, Davis AM, Harris JG, Soybilgic A, Onel KB, Schanberg LE, Rubinstein T, Gottlieb BS, Mandell DS, von Scheven E. Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada. Journal of Rheumatology. 2016 Jun;43(6):1136-45.
Rubinstein T, Putterman C, Goilav B. Biomarkers for CNS involvement in pediatric lupus. Biomarkers in Medicine. 2015;9(6):545-58.
Goilav B, Putterman C, Rubinstein T. Biomarkers for kidney involvement in pediatric lupus. Biomarkers in Medicine. 2015;9(6):529-43.
Rubinstein T,Pitashny M, Levine B, Schwartz N, Schwartzman J, Weinstein E, Pego-Reigosa JM, Lu TY, Isenberg D, Rahman A, Putterman C. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology. 2010 May;49(5):960-71.
Rubinstein T, Pitashny M, Putterman C. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for lupus nephritis. Autoimmunity Reviews. 2008 Jan;7(3):229-34.